Internal Server Error

Therapeutic Solutions International - About the company

Therapeutic Solutions International is a public company based in Oceanside (United States), founded in 2007. It operates as a Developer of immunotherapeutics for cancer and infectious diseases. Therapeutic Solutions International has raised an undisclosed amount in funding. The company has 3580 active competitors, including 1185 funded and 828 that have exited. Its top competitors include companies like Jazz Pharmaceuticals, BeiGene and Sana Biotechnology.

Company Details

Developer of immunotherapeutics for cancer and infectious diseases. It offers Umbilical Cord-derived Mesenchymal Stem Cells-based therapeutics for acute respiratory distress syndrome, Covid-19, chronic traumatic encephalopathy, solid tumors, and others.
Social
XFacebook
Key Metrics
Founded Year
2007
Location
Oceanside, United States
Stage
Public
Latest Funding Round
Investors
Ranked
Annual Revenue
$0 - $1M as on Dec 31, 2023
Employee Count
5 as on Jul 31, 2026
Similar Companies
Exit Details
Public

Therapeutic Solutions International's IPO details

Therapeutic Solutions International got listed on Apr 24, 2009.
Click here to take a look at Therapeutic Solutions International's IPO in detail
Sign up to download Therapeutic Solutions International's company profile

Therapeutic Solutions International's funding and investors

Therapeutic Solutions International has raised funding over 4 rounds. Its first funding round was on May 04, 2015. Therapeutic Solutions International has 1 institutional investor.

Here is the list of recent funding rounds of Therapeutic Solutions International:lockFilter this list
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
May 02, 2018
5559312
Post IPO
1609694
8602041
1574488
5462148
Sep 19, 2016
3492693
Post IPO
6810171
1354519
7159532
6819987
Feb 05, 2016
5640296
Post IPO
5135553
8277316
6769767
2355507
lockAccess funding benchmarks and valuations. Sign up today!

Therapeutic Solutions International's founders and board of directors

Founder? Claim Profile

Therapeutic Solutions International's employee count trend

Therapeutic Solutions International has 5 employees as of Jul 26. Here is Therapeutic Solutions International's employee count trend over the years:
Employee count trend for Therapeutic Solutions International
lockUncover Therapeutic Solutions International's growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

Therapeutic Solutions International's Competitors and alternates

Top competitors of Therapeutic Solutions International include Jazz Pharmaceuticals, BeiGene and Sana Biotechnology. Here is the list of Top 10 competitors of Therapeutic Solutions International, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Jazz Pharmaceuticals
Jazz Pharmaceuticals
2003, Dublin (Ireland), Public
Developer of novel biopharmaceutical medicines for unmet medical needs
$265M
81/100
2nd
Logo for BeiGene
BeiGene
2010, Cambridge (United States), Public
Developer of targeted and immune-oncology drugs against cancer
$172M
81/100
3rd
Logo for Sana Biotechnology
Sana Biotechnology
2018, Seattle (United States), Public
Developer of engineered cell therapies for treating various human diseases
$821M
74/100
4th
Logo for Ideaya Biosciences
Ideaya Biosciences
2015, San Francisco (United States), Public
Developer of oncology-focused precision medicine using molecular diagnostics
$157M
73/100
5th
Logo for Senti Bio
Senti Bio
2016, San Francisco (United States), Public
Developer of cell and gene therapies for patients living with incurable diseases
$158M
72/100
6th
Developer of antibody-based therapeutics for cancer therapy
$175M
72/100
7th
Logo for Syndax
Syndax
2005, Waltham (United States), Public
Developer of targeted therapies for the treatment of cancer
$198M
72/100
8th
Logo for Immuneel
Immuneel
2018, Bengaluru (India), Series B
Developer of T-cell therapies for the treatment of cancer
$49.8M
72/100
9th
Logo for Moderna
Moderna
2010, Cambridge (United States), Public
Developer of mRNA-based therapeutics for a wide range of diseases
$2.78B
72/100
10th
Logo for C4 Therapeutics
C4 Therapeutics
2016, Cambridge (United States), Public
Developer of small molecule drugs for treating cancer
$223M
71/100
1923rd
Developer of immunotherapeutics for cancer and infectious diseases
-
30/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on Therapeutic Solutions International's competitors? Click here to see the top ones

Therapeutic Solutions International's Investments and acquisitions

Therapeutic Solutions International has made no investments or acquisitions yet.

Reports related to Therapeutic Solutions International

Here is the latest report on Therapeutic Solutions International's sector:

News related to Therapeutic Solutions International

lockFilter this list
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about Therapeutic Solutions International

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford